# CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment

> **NCT00604357** · PHASE3 · COMPLETED · sponsor: **University of Regensburg** · enrollment: 27 (actual)

## Conditions studied

- End Stage Liver Disease
- Impaired Renal Function

## Interventions

- **DRUG:** anti-CD 25 mAb, Sirolimus, MMF

## Key facts

- **NCT ID:** NCT00604357
- **Lead sponsor:** University of Regensburg
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-07
- **Final completion:** 2012-08
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2014-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00604357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00604357, "CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00604357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*